🚨 The Panic Cycle Returns, Colorado Tightens The Sample

Built by a former cannabis regulator, Policy, Decoded helps operators read the policy terrain before it shifts beneath their feet.

Today’s edition tracks how fast legitimacy gets tested when the incentives line up. Colorado is moving to take sample selection out of operator hands because you cannot trust results if you cannot trust the sample. A fresh psychosis panic is ricocheting across social feeds, and the timing raises the same old question about who feels threatened as cannabis keeps taking share from legacy vice and wellness habits. New Jersey is tightening enforcement with better partners at the table, while still needing language and posture that protect equity gains, and banking remains a two-speed system where deposits are getting easier and credit still comes at a premium.

Policy Decoded is sponsored and supported today by Wispr Flow and Mindstream. Future sponsors? Possibly you?

A new episode of The Hybrid drops this week with special guest Adam Crabtree of NCS Analytics.

🧪 Testing starts with the sample
🚨 Narratives move faster than governance
🏦 Deposits improve, credit stays tight

Sunlight Is The Best Disinfectant.

🚨 The Psychosis Panic Has A Sponsor, Even If It Hides Offstage

A Fox News segment amplifies The New York Times editorial shift by emphasizing dependence risk, potency concerns, and mental health impacts, with commentary from Dr. Marc Siegel, Jonathan Caulkins, and Dr. Laura Gardner alongside a defense of regulated guardrails from UNLV’s Riana Durrett. Readers have also seen a sudden wave of social posts pushing the same psychosis frame, often delivered with the confidence of people who never have to write rules or run enforcement. The surge feels coordinated, and it raises the obvious question: who is threatened and by what, as cannabis keeps competing with alcohol, tobacco, and legacy wellness habits for the same adult consumer dollar. Cannabis carries real mental health risk for some people and deserves serious governance, and that truth gets warped when the narrative is used to declare it uniquely dangerous while older industries skate by with familiar harms. The right response is not panic and it is not denial, it is credible standards, clear dosing norms, honest education, and enforcement aimed where age gates are weakest. (Fox News; stupidDOPE)

🧪 Colorado May End “Pick Your Own Sample” Lab Testing

Colorado’s Marijuana Enforcement Division is weighing a shift that would stop manufacturers from selecting the samples they send for required lab testing, moving toward third-party or lab-collected sampling. Regulators and industry critics argue the current approach invites cherry-picking and manipulation, which can help contaminated or chemically altered products reach shelves. You cannot fix lab shopping if you cannot trust the sample, because every compliant step downstream becomes performance art when the starting material is suspect. MED deputy director Kyle Lambert said sample adulteration is a common violation, and reporting points to roughly two dozen testing-rule cases found by state officials in 2024 alone. If Colorado changes sampling, it strengthens the market’s credibility and gives other states a practical blueprint that does not depend on wishful thinking. (ProPublica)

📉 Colorado’s Sales Slide Looks Like Market Fluidity, Not A Moral Failure

Colorado Department of Revenue data shows dispensaries sold just over $1.1 billion from January through October 2025, putting the state on track for a fourth straight year of declining sales. A national cannabis market is emerging in real time, and it is normal for mature states to lose some edge as more states legalize and intoxicating hemp earns shelf space. Westword notes retail sales peaked at more than $2.2 billion in 2022, and the median wholesale price per pound has sunk to record lows, with flower hitting $648 in December. The cultivation footprint is thinning with a 48 percent drop in licensed recreational grows from 2021 to 2025, and that is what a margin squeeze looks like when supply outpaces demand. The takeaway stays the same: plan for an uncertain future, watch margins and COGS like a hawk, and avoid building a business model that only works in yesterday’s price environment. (Westword)

🚓 New Jersey Puts Enforcement On A Task Force Track

NJ Cannabis Regulatory Commission commissioners Amelia Mapp and Harris Laufer used the Ignite It NJ Spotlight conference to preview a tougher posture toward unlicensed smoke shops and the underground market. Laufer pointed to the CRC’s enforcement structure with the Attorney General and State Police, which matches tools to the problem and keeps the CRC honest about its own limits. New Jersey is serving its licensed industry by squeezing the gray market, and that is part of governing a regulated system. The language still matters in a state with a long memory of unequal enforcement, and task force talk can spook communities the equity program is supposed to serve. If New Jersey wants to protect its equity gains, it should lead with legitimacy and consumer protection, then do the work with partners who can carry the enforcement load. (Heady NJ)

🏦 Cannabis Banking Has Improved, Credit Still Lags

Bloomberg profiles a Brooklyn dispensary operating inside a former bank building that still has to move cash by armored car and run debit as ATM-style withdrawals because mainstream payment rails remain closed. Federal illegality keeps big banks and card networks cautious and forces operators into smaller banks, credit unions, and compliance-heavy workarounds. The story is not all doom: deposit access has improved, more institutions have stepped in, and fees have come down for many operators, even without Congress doing its job. FinCEN reported 816 financial institutions serving cannabis at the end of 2024, meaningful progress that still falls short of normal banking. Lending remains the choke point, with hard collateral demands and expensive credit that punishes growth and rewards incumbency. Until Congress delivers a banking fix that banks trust, capital stays uneven, and the market keeps pricing that risk into who survives. (Bloomberg Businessweek)

🛣️ Michigan’s Cannabis Tax Case Puts Roads In The Middle

The County Road Association of Michigan (that is a thing - I looked it up!) filed an amicus brief in the lawsuit challenging the state’s 24% wholesale marijuana tax, arguing the revenue is already built into road and bridge planning. CEO Denise Donohue framed the levy as a long-term hedge as fuel consumption trends down, effectively treating cannabis revenue as structural budget support. There is a road lobby because everything has a lobby now, and the roads have advocates too. The harder question is why cannabis is the dedicated funding lane here, as if dispensary receipts are uniquely responsible for potholes in a way general taxation is not. If the court narrows the tax, Lansing either backfills infrastructure dollars quickly or accepts visible service degradation, and operators get a pricing reset that changes who can expand and who can survive. (Upper Michigan’s Source WLUC)

🤢 Virginia’s CHS Spike Needs A Health Plan, Not A Freakout

Virginia hospital data shows adult emergency department visits linked to cannabinoid hyperemesis syndrome rose about 29% from 2020 to 2024, totaling roughly 24,960 CHS-associated visits across five years. The same dataset tracks more than 172,000 cannabis-related visits tied to abuse, dependence, or poisoning diagnoses, which gives the CHS number scale and context. This is a predictable storyline in every emerging market: the emergency room headline that becomes a proxy war about legalization itself. Health and welfare is a pillar of legalization, which is why warning labels, safe use guidance, and public education should show up early and stay funded. People land in emergency rooms for plenty of legal products, and Tide pods have their own chapter, so the serious response is better guidance and better guardrails rather than theatrical panic. (WAVY)

🩺 South Dakota Holds The Line While Oklahoma Talks Repeal

Sen. John Carley brought two bills to the Senate Health and Human Services Committee that aimed to dismantle South Dakota’s medical program and impose potency caps that would have narrowed patient options sharply. The committee rejected SB 181 7-0, which would have repealed the voter-approved program 90 days after a federal rescheduling process is finalized. It also rejected his potency bill 6-1 after he proposed caps of 5% THC for oils and 60% for liquid concentrates. The Department of Health opposed repeal, and Marijuana Policy Project warned the change would strip protections and access from roughly 18,000 patients. The contrast worth noting is political, not pharmacological: South Dakota refused to tie patient rights to an uncertain federal process while Oklahoma’s governor is publicly flirting with repeal, and that divergence shapes how much patients can trust their state to keep its promises. (Marijuana Moment)

🪪 Mississippi Moves Medical From Paperwork Toward Practice

Mississippi House lawmakers advanced two bills aimed at a common friction point in newer programs: patients and caregivers getting trapped in recurring administrative loops that do not add safety. Rep. Lee Yancey’s ID bill would extend patient certification validity from one year to two, remove the mandatory six-month follow-up visit requirement, and extend resident-designated caregiver validity up to five years, passing 98-11. His separate right-to-try bill would create a petition pathway through the Mississippi State Department of Health for patients with debilitating conditions not on the qualifying list, with case-by-case approval and an annual re-evaluation, passing 104-7. The governing value is that it puts medicine back with clinicians and the health officer rather than forcing lawmakers to micromanage a condition list. If the Senate agrees, patients get stability and the program gets easier to administer without turning access into a loophole. (Ganjapreneur)

🧀 Wisconsin’s “Decriminalization” Still Keeps Jail On The Table

Reps. Sylvia Ortiz-Velez and Shae Sortwell are circulating a bipartisan bill to decriminalize first-time marijuana possession in Wisconsin, with formal filing still pending. The draft sets a $100 fine for a first offense up to 28 grams with no jail time, while possession above 28 grams would still carry a $1,000 fine and up to 90 days in jail. That jail hook is the tell, because a state that truly believes simple possession should not be a criminal justice issue does not keep incarceration as an option on the next rung. There is room for hard lines where harm is real, including sales or diversion to kids, and enforcement there earns legitimacy. If Wisconsin wants a middle step that the public can respect, it should stop treating adult possession as a jailable offense and put its enforcement energy where public safety stakes actually live. (Marijuana Moment)

🌽 Indiana Feels The Border Pressure In Real Dollars

An opinion piece in the Indiana Daily Student captures what statehouses feel even when they refuse to say it aloud: residents are already accessing neighboring markets and paying those taxes elsewhere. The column points to bills moving through the General Assembly, including Rep. Jim Lucas’s HB 1298 tied to federal scheduling posture, Rep. Mitch Gore’s HB 1191 to decriminalize up to two ounces, and Senate proposals to create an Indiana Cannabis Commission and tighten THC product definitions. The author treats federal rescheduling talk as political noise more than a governing plan, which aligns with what local officials need to hear. Indiana’s choice is to regulate demand with standards and revenue or keep outsourcing both to Michigan and Illinois while fighting whack-a-mole enforcement around intoxicating hemp. The longer the delay, the more the state normalizes a market it does not regulate and a tax stream it does not collect. (Indiana Daily Student)

🪷 Hawaii Has Been On The Doorstep For Years

Hawaii’s main legalization vehicles, HB 1246 and SB 1613, are widely viewed as dead for the 2026 session after key lawmakers signaled they will not be scheduled for the hearings needed to advance. A separate voter-ballot path through a constitutional amendment faces procedural hurdles and timing friction that make it a long shot this year. Hawaii has real operational hurdles, including inventory planning and supply chain logistics across islands, and those are exactly the problems a comprehensive plan is supposed to solve rather than avoid. Each year of delay preserves unregulated purchasing while denying policymakers the chance to set standards on age access, labeling, and product safety. If Hawaii wants adult use, it needs leadership willing to own implementation details in public and build a system that fits the geography instead of pretending the geography is an excuse. (Marijuana Moment)